Evofem Biosciences, Inc.
EVFM
$0.01
$0.00-8.54%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -94.83% | 104.41% | 31.54% | -110.31% | -106.13% |
| Total Depreciation and Amortization | -51.09% | -17.20% | 111.03% | 560.00% | 552.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 171.52% | -207.16% | -26.18% | 97.52% | 92.60% |
| Change in Net Operating Assets | -45.02% | -32.76% | -69.38% | -73.37% | -66.26% |
| Cash from Operations | 92.72% | 48.73% | -169.03% | -47.13% | 11.70% |
| Capital Expenditure | -- | 64.29% | 85.71% | 85.71% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 200.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 90.69% | 79.46% | -- | -- | -- |
| Cash from Investing | 98.86% | 89.10% | 79.92% | -4,285.71% | -3,980.00% |
| Total Debt Issued | 607.30% | 607.30% | 262.32% | -27.98% | -90.08% |
| Total Debt Repaid | -38.28% | -15.73% | -33.63% | 35.18% | 20.54% |
| Issuance of Common Stock | -- | -- | 4,210.34% | 3,746.15% | 2,083.41% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -200.00% | -200.00% | -- |
| Cash from Financing | -65.89% | -59.02% | 87.51% | 62.78% | 45.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 202.38% | -201.24% | -62.18% | 0.00% | 149.70% |